bionlp-st-ge-2016-spacy-parsed Home  

PMC:3312845 / 6753-8147 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T3586 0-4 NNS denotes Rats
T3587 5-9 VBD denotes were
T3588 10-17 VBN denotes divided
T3589 18-22 IN denotes into
T3590 23-26 CD denotes two
T3591 27-33 NNS denotes groups
T3592 33-34 : denotes :
T3593 35-42 NN denotes vehicle
T3594 43-44 -LRB- denotes (
T3595 44-50 NN denotes saline
T3596 50-51 -RRB- denotes )
T3597 51-52 : denotes -
T3598 52-59 VBN denotes treated
T3599 60-63 CC denotes and
T3600 64-71 JJ denotes soluble
T3601 72-78 NN denotes TNFp55
T3602 79-87 NN denotes receptor
T3603 88-89 -LRB- denotes (
T3604 89-97 JJ denotes sTNFp55R
T3605 97-98 , denotes ,
T3606 99-101 CD denotes 50
T3607 102-104 NN denotes μg
T3608 104-105 NN denotes /
T3609 105-107 NN denotes ml
T3610 107-108 : denotes ;
T3611 109-122 NNP denotes Sigma-Aldrich
T3612 123-126 NNP denotes Co.
T3613 126-127 , denotes ,
T3614 128-131 NNP denotes St.
T3615 132-137 NNP denotes Louis
T3616 137-138 , denotes ,
T3617 139-141 NNP denotes MO
T3618 141-142 -RRB- denotes )
T3619 142-143 : denotes -
T3620 143-150 VBN denotes treated
T3621 151-157 NNS denotes groups
T3622 157-158 . denotes .
T3623 159-162 DT denotes The
T3624 163-169 NN denotes dosage
T3625 170-172 IN denotes of
T3626 173-181 NN denotes sTNFp55R
T3627 182-185 VBD denotes was
T3628 186-196 VBN denotes determined
T3629 197-199 IN denotes as
T3630 200-203 DT denotes the
T3631 204-211 JJS denotes highest
T3632 212-216 NN denotes dose
T3633 217-221 WDT denotes that
T3634 222-229 VBD denotes induced
T3635 230-232 NNP denotes SE
T3636 233-235 IN denotes of
T3637 236-246 JJ denotes comparable
T3638 247-255 NN denotes severity
T3639 256-258 IN denotes in
T3640 259-262 CD denotes 100
T3641 262-263 NN denotes %
T3642 264-266 IN denotes of
T3643 267-274 NNS denotes animals
T3644 275-279 IN denotes with
T3645 280-281 CD denotes 5
T3646 281-282 NN denotes %
T3647 283-292 NN denotes mortality
T3648 293-295 IN denotes in
T3649 296-299 DT denotes the
T3650 300-311 JJ denotes preliminary
T3651 312-317 NN denotes study
T3652 317-318 . denotes .
T3653 319-326 NNS denotes Animals
T3654 327-331 VBD denotes were
T3655 332-344 JJ denotes anesthetized
T3656 345-346 -LRB- denotes (
T3657 346-354 NNP denotes Zolretil
T3658 354-355 , denotes ,
T3659 356-358 CD denotes 50
T3660 359-364 NN denotes mg/kg
T3661 364-365 , denotes ,
T3662 366-370 NN denotes i.m.
T3663 370-371 : denotes ;
T3664 372-378 NNP denotes Virbac
T3665 379-391 NNPS denotes Laboratories
T3666 391-392 , denotes ,
T3667 393-399 NNP denotes France
T3668 399-400 -RRB- denotes )
T3669 401-404 CC denotes and
T3670 405-411 VBN denotes placed
T3671 412-414 IN denotes in
T3672 415-416 DT denotes a
T3673 417-428 JJ denotes stereotaxic
T3674 429-435 NNS denotes frames
T3675 435-436 . denotes .
T3676 437-440 IN denotes For
T3677 441-444 DT denotes the
T3678 445-452 JJ denotes osmotic
T3679 453-457 NN denotes pump
T3680 458-470 NN denotes implantation
T3681 470-471 , denotes ,
T3682 472-477 NNS denotes holes
T3683 478-482 VBD denotes were
T3684 483-490 VBN denotes drilled
T3685 491-498 IN denotes through
T3686 499-502 DT denotes the
T3687 503-508 NN denotes skull
T3688 509-511 TO denotes to
T3689 512-521 VB denotes introduce
T3690 522-523 DT denotes a
T3691 524-529 NN denotes brain
T3692 530-538 NN denotes infusion
T3693 539-542 NN denotes kit
T3694 543-544 CD denotes 1
T3695 545-546 -LRB- denotes (
T3696 546-551 NNP denotes Alzet
T3697 551-552 , denotes ,
T3698 553-562 NNP denotes Cupertino
T3699 562-563 , denotes ,
T3700 564-566 NNP denotes CA
T3701 566-567 -RRB- denotes )
T3702 568-572 IN denotes into
T3703 573-576 DT denotes the
T3704 577-582 JJ denotes right
T3705 583-590 JJ denotes lateral
T3706 591-600 NN denotes ventricle
T3707 601-602 -LRB- denotes (
T3708 602-603 CD denotes 1
T3709 604-606 NN denotes mm
T3710 607-616 NN denotes posterior
T3711 616-617 : denotes ;
T3712 618-621 CD denotes 1.5
T3713 622-624 NN denotes mm
T3714 625-632 NN denotes lateral
T3715 632-633 : denotes ;
T3716 634-635 : denotes -
T3717 636-639 CD denotes 3.5
T3718 640-642 NN denotes mm
T3719 643-648 NN denotes depth
T3720 648-649 : denotes ;
T3721 650-654 JJ denotes flat
T3722 655-660 NN denotes skull
T3723 661-669 NN denotes position
T3724 670-674 IN denotes with
T3725 675-681 NN denotes bregma
T3726 682-684 IN denotes as
T3727 685-694 NN denotes reference
T3728 694-695 -RRB- denotes )
T3729 695-696 , denotes ,
T3730 697-706 VBG denotes according
T3731 707-709 TO denotes to
T3732 710-713 DT denotes the
T3733 714-719 NNS denotes atlas
T3734 720-722 IN denotes of
T3735 723-730 NNP denotes Paxinos
T3736 731-734 CC denotes and
T3737 735-741 NNP denotes Watson
T3738 742-743 NNP denotes [
T3739 743-745 CD denotes 24
T3740 745-746 NNP denotes ]
T3741 746-747 . denotes .
T3742 748-751 DT denotes The
T3743 752-760 NN denotes infusion
T3744 761-764 NN denotes kit
T3745 765-768 VBD denotes was
T3746 769-775 VBN denotes sealed
T3747 776-780 IN denotes with
T3748 781-787 JJ denotes dental
T3749 788-794 NN denotes cement
T3750 795-798 CC denotes and
T3751 799-808 VBN denotes connected
T3752 809-811 TO denotes to
T3753 812-814 DT denotes an
T3754 815-822 JJ denotes osmotic
T3755 823-827 NN denotes pump
T3756 828-829 -LRB- denotes (
T3757 829-834 NNP denotes 1007D
T3758 834-835 , denotes ,
T3759 836-841 NNP denotes Alzet
T3760 841-842 , denotes ,
T3761 843-852 NNP denotes Cupertino
T3762 852-853 , denotes ,
T3763 854-856 NNP denotes CA
T3764 856-857 -RRB- denotes )
T3765 857-858 . denotes .
T3766 859-862 DT denotes The
T3767 863-867 NN denotes pump
T3768 868-871 VBD denotes was
T3769 872-878 VBN denotes placed
T3770 879-881 IN denotes in
T3771 882-883 DT denotes a
T3772 884-896 JJ denotes subcutaneous
T3773 897-903 NN denotes pocket
T3774 904-906 IN denotes in
T3775 907-910 DT denotes the
T3776 911-917 JJ denotes dorsal
T3777 918-924 NN denotes region
T3778 924-925 . denotes .
T3779 926-933 NNS denotes Animals
T3780 934-942 VBD denotes received
T3781 943-946 CD denotes 0.5
T3782 947-949 NN denotes μl
T3783 949-950 NN denotes /
T3784 950-952 NN denotes hr
T3785 953-955 IN denotes of
T3786 956-963 NN denotes vehicle
T3787 964-966 CC denotes or
T3788 967-975 NN denotes compound
T3789 976-979 IN denotes for
T3790 980-981 CD denotes 1
T3791 982-986 NN denotes week
T3792 986-987 . denotes .
T3793 988-997 RB denotes Therefore
T3794 997-998 , denotes ,
T3795 999-1002 DT denotes the
T3796 1003-1007 NN denotes dose
T3797 1008-1010 IN denotes of
T3798 1011-1019 NN denotes sTNFp55R
T3799 1020-1023 VBD denotes was
T3800 1024-1027 CD denotes 0.6
T3801 1028-1030 NN denotes μg
T3802 1030-1031 NN denotes /
T3803 1031-1034 NN denotes day
T3804 1035-1038 IN denotes per
T3805 1039-1043 DT denotes each
T3806 1044-1050 NN denotes animal
T3807 1050-1051 . denotes .
T3808 1052-1055 DT denotes The
T3809 1056-1065 NNS denotes compounds
T3810 1066-1071 VBD denotes began
T3811 1072-1074 TO denotes to
T3812 1075-1077 VB denotes be
T3813 1078-1089 RB denotes immediately
T3814 1090-1097 VBN denotes infused
T3815 1098-1103 IN denotes after
T3816 1104-1111 NN denotes surgery
T3817 1111-1112 . denotes .
T3818 1113-1118 IN denotes Since
T3819 1119-1122 DT denotes the
T3820 1123-1129 NN denotes volume
T3821 1130-1132 IN denotes of
T3822 1133-1142 JJ denotes vasogenic
T3823 1143-1148 NN denotes edema
T3824 1149-1155 VBD denotes peaked
T3825 1156-1158 IN denotes at
T3826 1159-1162 CD denotes 2-3
T3827 1163-1167 NNS denotes days
T3828 1168-1173 IN denotes after
T3829 1174-1176 NNP denotes SE
T3830 1177-1179 IN denotes in
T3831 1180-1183 PRP$ denotes our
T3832 1184-1192 JJ denotes previous
T3833 1193-1200 NNS denotes studies
T3834 1201-1202 NNP denotes [
T3835 1202-1205 CD denotes 5-8
T3836 1205-1208 CD denotes ,20
T3837 1208-1209 NNP denotes ]
T3838 1209-1210 , denotes ,
T3839 1211-1213 PRP denotes we
T3840 1214-1219 VBD denotes chose
T3841 1220-1224 DT denotes this
T3842 1225-1229 NN denotes time
T3843 1230-1235 NN denotes point
T3844 1235-1236 . denotes .
T3845 1237-1241 RB denotes Thus
T3846 1241-1242 , denotes ,
T3847 1243-1246 PRP$ denotes our
T3848 1247-1259 JJ denotes experimental
T3849 1260-1269 NNS denotes schedules
T3850 1270-1272 IN denotes at
T3851 1273-1278 JJS denotes least
T3852 1279-1286 VB denotes inhibit
T3853 1287-1290 DT denotes the
T3854 1291-1299 NN denotes function
T3855 1300-1302 IN denotes of
T3856 1303-1308 NN denotes TNF-α
T3857 1309-1313 IN denotes from
T3858 1314-1315 CD denotes 3
T3859 1316-1320 NNS denotes days
T3860 1321-1326 RB denotes prior
T3861 1327-1329 TO denotes to
T3862 1330-1332 VB denotes SE
T3863 1333-1335 TO denotes to
T3864 1336-1337 CD denotes 4
T3865 1338-1342 NNS denotes days
T3866 1343-1348 IN denotes after
T3867 1349-1351 NNP denotes SE
T3868 1352-1356 WRB denotes when
T3869 1357-1360 DT denotes the
T3870 1361-1367 NN denotes volume
T3871 1368-1370 IN denotes of
T3872 1371-1380 JJ denotes vasogenic
T3873 1381-1386 NN denotes edema
T3874 1387-1393 VBD denotes peaked
T3875 1393-1394 . denotes .
R2731 T3586 T3588 nsubjpass Rats,divided
R2732 T3587 T3588 auxpass were,divided
R2733 T3588 T3588 ROOT divided,divided
R2734 T3589 T3588 prep into,divided
R2735 T3590 T3591 nummod two,groups
R2736 T3591 T3589 pobj groups,into
R2737 T3592 T3591 punct :,groups
R2738 T3593 T3591 appos vehicle,groups
R2739 T3594 T3595 punct (,saline
R2740 T3595 T3593 appos saline,vehicle
R2741 T3596 T3593 punct ),vehicle
R2742 T3597 T3593 punct -,vehicle
R2743 T3598 T3593 acl treated,vehicle
R2744 T3599 T3598 cc and,treated
R2745 T3600 T3598 conj soluble,treated
R2746 T3601 T3602 compound TNFp55,receptor
R2747 T3602 T3620 ccomp receptor,treated
R2748 T3603 T3609 punct (,ml
R2749 T3604 T3609 amod sTNFp55R,ml
R2750 T3605 T3609 punct ",",ml
R2751 T3606 T3607 nummod 50,μg
R2752 T3607 T3609 nmod μg,ml
R2753 T3608 T3609 compound /,ml
R2754 T3609 T3602 appos ml,receptor
R2755 T3610 T3620 punct ;,treated
R2756 T3611 T3612 compound Sigma-Aldrich,Co.
R2757 T3612 T3620 nsubj Co.,treated
R2758 T3613 T3612 punct ",",Co.
R2759 T3614 T3615 compound St.,Louis
R2760 T3615 T3612 npadvmod Louis,Co.
R2761 T3616 T3612 punct ",",Co.
R2762 T3617 T3612 appos MO,Co.
R2763 T3618 T3617 punct ),MO
R2764 T3619 T3620 punct -,treated
R2765 T3620 T3621 amod treated,groups
R2766 T3621 T3591 appos groups,groups
R2767 T3622 T3588 punct .,divided
R2768 T3623 T3624 det The,dosage
R2769 T3624 T3628 nsubjpass dosage,determined
R2770 T3625 T3624 prep of,dosage
R2771 T3626 T3625 pobj sTNFp55R,of
R2772 T3627 T3628 auxpass was,determined
R2773 T3628 T3628 ROOT determined,determined
R2774 T3629 T3628 prep as,determined
R2775 T3630 T3632 det the,dose
R2776 T3631 T3632 amod highest,dose
R2777 T3632 T3629 pobj dose,as
R2778 T3633 T3634 nsubj that,induced
R2779 T3634 T3632 relcl induced,dose
R2780 T3635 T3634 dobj SE,induced
R2781 T3636 T3635 prep of,SE
R2782 T3637 T3638 amod comparable,severity
R2783 T3638 T3636 pobj severity,of
R2784 T3639 T3634 prep in,induced
R2785 T3640 T3641 nummod 100,%
R2786 T3641 T3639 pobj %,in
R2787 T3642 T3641 prep of,%
R2788 T3643 T3642 pobj animals,of
R2789 T3644 T3634 prep with,induced
R2790 T3645 T3646 nummod 5,%
R2791 T3646 T3647 compound %,mortality
R2792 T3647 T3644 pobj mortality,with
R2793 T3648 T3647 prep in,mortality
R2794 T3649 T3651 det the,study
R2795 T3650 T3651 amod preliminary,study
R2796 T3651 T3648 pobj study,in
R2797 T3652 T3628 punct .,determined
R2798 T3653 T3654 nsubj Animals,were
R2799 T3654 T3665 ccomp were,Laboratories
R2800 T3655 T3654 acomp anesthetized,were
R2801 T3656 T3657 punct (,Zolretil
R2802 T3657 T3665 ccomp Zolretil,Laboratories
R2803 T3658 T3657 punct ",",Zolretil
R2804 T3659 T3660 nummod 50,mg/kg
R2805 T3660 T3657 appos mg/kg,Zolretil
R2806 T3661 T3662 punct ",",i.m.
R2807 T3662 T3657 conj i.m.,Zolretil
R2808 T3663 T3665 punct ;,Laboratories
R2809 T3664 T3665 compound Virbac,Laboratories
R2810 T3665 T3665 ROOT Laboratories,Laboratories
R2811 T3666 T3665 punct ",",Laboratories
R2812 T3667 T3665 conj France,Laboratories
R2813 T3668 T3667 punct ),France
R2814 T3669 T3665 cc and,Laboratories
R2815 T3670 T3665 conj placed,Laboratories
R2816 T3671 T3670 prep in,placed
R2817 T3672 T3674 det a,frames
R2818 T3673 T3674 amod stereotaxic,frames
R2819 T3674 T3671 pobj frames,in
R2820 T3675 T3665 punct .,Laboratories
R2821 T3676 T3684 prep For,drilled
R2822 T3677 T3680 det the,implantation
R2823 T3678 T3680 amod osmotic,implantation
R2824 T3679 T3680 compound pump,implantation
R2825 T3680 T3676 pobj implantation,For
R2826 T3681 T3684 punct ",",drilled
R2827 T3682 T3684 nsubjpass holes,drilled
R2828 T3683 T3684 auxpass were,drilled
R2829 T3684 T3684 ROOT drilled,drilled
R2830 T3685 T3684 prep through,drilled
R2831 T3686 T3687 det the,skull
R2832 T3687 T3685 pobj skull,through
R2833 T3688 T3689 aux to,introduce
R2834 T3689 T3684 advcl introduce,drilled
R2835 T3690 T3693 det a,kit
R2836 T3691 T3692 compound brain,infusion
R2837 T3692 T3693 compound infusion,kit
R2838 T3693 T3689 dobj kit,introduce
R2839 T3694 T3693 nummod 1,kit
R2840 T3695 T3693 punct (,kit
R2841 T3696 T3693 appos Alzet,kit
R2842 T3697 T3696 punct ",",Alzet
R2843 T3698 T3696 conj Cupertino,Alzet
R2844 T3699 T3698 punct ",",Cupertino
R2845 T3700 T3698 conj CA,Cupertino
R2846 T3701 T3693 punct ),kit
R2847 T3702 T3689 prep into,introduce
R2848 T3703 T3706 det the,ventricle
R2849 T3704 T3706 amod right,ventricle
R2850 T3705 T3706 amod lateral,ventricle
R2851 T3706 T3702 pobj ventricle,into
R2852 T3707 T3710 punct (,posterior
R2853 T3708 T3709 nummod 1,mm
R2854 T3709 T3710 compound mm,posterior
R2855 T3710 T3723 compound posterior,position
R2856 T3711 T3710 punct ;,posterior
R2857 T3712 T3713 nummod 1.5,mm
R2858 T3713 T3714 compound mm,lateral
R2859 T3714 T3710 appos lateral,posterior
R2860 T3715 T3710 punct ;,posterior
R2861 T3716 T3710 punct -,posterior
R2862 T3717 T3718 nummod 3.5,mm
R2863 T3718 T3719 compound mm,depth
R2864 T3719 T3710 appos depth,posterior
R2865 T3720 T3710 punct ;,posterior
R2866 T3721 T3722 amod flat,skull
R2867 T3722 T3723 compound skull,position
R2868 T3723 T3689 dobj position,introduce
R2869 T3724 T3689 prep with,introduce
R2870 T3725 T3724 pobj bregma,with
R2871 T3726 T3689 prep as,introduce
R2872 T3727 T3726 pobj reference,as
R2873 T3728 T3689 punct ),introduce
R2874 T3729 T3684 punct ",",drilled
R2875 T3730 T3684 prep according,drilled
R2876 T3731 T3730 prep to,according
R2877 T3732 T3733 det the,atlas
R2878 T3733 T3731 pobj atlas,to
R2879 T3734 T3733 prep of,atlas
R2880 T3735 T3734 pobj Paxinos,of
R2881 T3736 T3735 cc and,Paxinos
R2882 T3737 T3738 compound Watson,[
R2883 T3738 T3735 conj [,Paxinos
R2884 T3739 T3740 nummod 24,]
R2885 T3740 T3735 conj ],Paxinos
R2886 T3741 T3684 punct .,drilled
R2887 T3742 T3744 det The,kit
R2888 T3743 T3744 compound infusion,kit
R2889 T3744 T3746 nsubjpass kit,sealed
R2890 T3745 T3746 auxpass was,sealed
R2891 T3746 T3746 ROOT sealed,sealed
R2892 T3747 T3746 prep with,sealed
R2893 T3748 T3749 amod dental,cement
R2894 T3749 T3747 pobj cement,with
R2895 T3750 T3749 cc and,cement
R2896 T3751 T3746 conj connected,sealed
R2897 T3752 T3751 prep to,connected
R2898 T3753 T3755 det an,pump
R2899 T3754 T3755 amod osmotic,pump
R2900 T3755 T3752 pobj pump,to
R2901 T3756 T3755 punct (,pump
R2902 T3757 T3757 ROOT 1007D,1007D
R2903 T3758 T3757 punct ",",1007D
R2904 T3759 T3757 conj Alzet,1007D
R2905 T3760 T3759 punct ",",Alzet
R2906 T3761 T3759 conj Cupertino,Alzet
R2907 T3762 T3761 punct ",",Cupertino
R2908 T3763 T3761 conj CA,Cupertino
R2909 T3764 T3757 punct ),1007D
R2910 T3765 T3746 punct .,sealed
R2911 T3766 T3767 det The,pump
R2912 T3767 T3769 nsubjpass pump,placed
R2913 T3768 T3769 auxpass was,placed
R2914 T3769 T3769 ROOT placed,placed
R2915 T3770 T3769 prep in,placed
R2916 T3771 T3773 det a,pocket
R2917 T3772 T3773 amod subcutaneous,pocket
R2918 T3773 T3770 pobj pocket,in
R2919 T3774 T3773 prep in,pocket
R2920 T3775 T3777 det the,region
R2921 T3776 T3777 amod dorsal,region
R2922 T3777 T3774 pobj region,in
R2923 T3778 T3769 punct .,placed
R2924 T3779 T3780 nsubj Animals,received
R2925 T3780 T3780 ROOT received,received
R2926 T3781 T3782 nummod 0.5,μl
R2927 T3782 T3784 compound μl,hr
R2928 T3783 T3784 compound /,hr
R2929 T3784 T3780 dobj hr,received
R2930 T3785 T3784 prep of,hr
R2931 T3786 T3785 pobj vehicle,of
R2932 T3787 T3786 cc or,vehicle
R2933 T3788 T3786 conj compound,vehicle
R2934 T3789 T3780 prep for,received
R2935 T3790 T3791 nummod 1,week
R2936 T3791 T3789 pobj week,for
R2937 T3792 T3780 punct .,received
R2938 T3793 T3799 advmod Therefore,was
R2939 T3794 T3799 punct ",",was
R2940 T3795 T3796 det the,dose
R2941 T3796 T3799 nsubj dose,was
R2942 T3797 T3796 prep of,dose
R2943 T3798 T3797 pobj sTNFp55R,of
R2944 T3799 T3799 ROOT was,was
R2945 T3800 T3801 nummod 0.6,μg
R2946 T3801 T3803 amod μg,day
R2947 T3802 T3803 compound /,day
R2948 T3803 T3799 attr day,was
R2949 T3804 T3803 prep per,day
R2950 T3805 T3806 det each,animal
R2951 T3806 T3804 pobj animal,per
R2952 T3807 T3799 punct .,was
R2953 T3808 T3809 det The,compounds
R2954 T3809 T3810 nsubj compounds,began
R2955 T3810 T3810 ROOT began,began
R2956 T3811 T3814 aux to,infused
R2957 T3812 T3814 auxpass be,infused
R2958 T3813 T3814 advmod immediately,infused
R2959 T3814 T3810 xcomp infused,began
R2960 T3815 T3814 prep after,infused
R2961 T3816 T3815 pobj surgery,after
R2962 T3817 T3810 punct .,began
R2963 T3818 T3824 mark Since,peaked
R2964 T3819 T3820 det the,volume
R2965 T3820 T3824 nsubj volume,peaked
R2966 T3821 T3820 prep of,volume
R2967 T3822 T3823 amod vasogenic,edema
R2968 T3823 T3821 pobj edema,of
R2969 T3824 T3840 advcl peaked,chose
R2970 T3825 T3824 prep at,peaked
R2971 T3826 T3827 nummod 2-3,days
R2972 T3827 T3825 pobj days,at
R2973 T3828 T3840 prep after,chose
R2974 T3829 T3837 nmod SE,]
R2975 T3830 T3829 prep in,SE
R2976 T3831 T3833 poss our,studies
R2977 T3832 T3833 amod previous,studies
R2978 T3833 T3830 pobj studies,in
R2979 T3834 T3837 nmod [,]
R2980 T3835 T3834 nummod 5-8,[
R2981 T3836 T3837 compound ",20",]
R2982 T3837 T3828 pobj ],after
R2983 T3838 T3840 punct ",",chose
R2984 T3839 T3840 nsubj we,chose
R2985 T3840 T3840 ROOT chose,chose
R2986 T3841 T3843 det this,point
R2987 T3842 T3843 compound time,point
R2988 T3843 T3840 dobj point,chose
R2989 T3844 T3840 punct .,chose
R2990 T3845 T3852 advmod Thus,inhibit
R2991 T3846 T3852 punct ",",inhibit
R2992 T3847 T3849 poss our,schedules
R2993 T3848 T3849 amod experimental,schedules
R2994 T3849 T3852 nsubj schedules,inhibit
R2995 T3850 T3851 advmod at,least
R2996 T3851 T3852 advmod least,inhibit
R2997 T3852 T3852 ROOT inhibit,inhibit
R2998 T3853 T3854 det the,function
R2999 T3854 T3852 dobj function,inhibit
R3000 T3855 T3854 prep of,function
R3001 T3856 T3855 pobj TNF-α,of
R3002 T3857 T3852 prep from,inhibit
R3003 T3858 T3859 nummod 3,days
R3004 T3859 T3857 pobj days,from
R3005 T3860 T3852 advmod prior,inhibit
R3006 T3861 T3860 prep to,prior
R3007 T3862 T3861 pobj SE,to
R3008 T3863 T3862 prep to,SE
R3009 T3864 T3865 nummod 4,days
R3010 T3865 T3863 pobj days,to
R3011 T3866 T3852 prep after,inhibit
R3012 T3867 T3866 pobj SE,after
R3013 T3868 T3874 advmod when,peaked
R3014 T3869 T3870 det the,volume
R3015 T3870 T3874 nsubj volume,peaked
R3016 T3871 T3870 prep of,volume
R3017 T3872 T3873 amod vasogenic,edema
R3018 T3873 T3871 pobj edema,of
R3019 T3874 T3852 advcl peaked,inhibit
R3020 T3875 T3852 punct .,inhibit